American Liver Foundation Leverages Boston Marathon for Awareness, Funding
Event summary
- The American Liver Foundation (ALF) is participating in the 130th Boston Marathon on April 20, 2026, with 'Team ALF' to raise funds and awareness for liver disease.
- Team ALF has been a Boston Marathon participant since 1989, historically contributing to ALF's mission.
- Damian Delaney, ALF's National LIVEr Champion, is running to promote living liver donation.
- Funds raised will support ALF programs including the 'Think Liver Think Life' campaign, Living Donor Network, and advocacy efforts.
The big picture
The American Liver Foundation's reliance on events like the Boston Marathon highlights the challenges faced by non-profits in securing consistent funding. With approximately 100 million Americans affected by liver disease, ALF's efforts are crucial, but their dependence on volunteer runners and event-driven fundraising creates inherent volatility. The focus on living donation underscores a growing trend towards innovative solutions in organ transplantation, but also emphasizes the need for broader public awareness and donor recruitment.
What we're watching
- Fundraising Efficiency
- The success of ALF's fundraising efforts will depend on the team's ability to attract donors and the effectiveness of their online campaign, given the increasing competition for charitable contributions.
- Living Donation
- The impact of Delaney's advocacy for living liver donation will be measured by whether it translates into a tangible increase in donor registrations and ultimately, successful transplants.
- Program Sustainability
- ALF's ability to sustain its programs, like 'Think Liver Think Life,' hinges on consistent fundraising and may be challenged by broader economic conditions impacting charitable giving.
Related topics